Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2024 | $8.25 | Sell → Neutral | Compass Point |
| 2/28/2024 | Buy → Neutral | Ladenburg Thalmann | |
| 1/8/2024 | $11.00 | Neutral → Sell | B. Riley Securities |
| 10/17/2023 | $10.00 | Neutral → Sell | Compass Point |
| 9/27/2023 | $11.00 → $10.50 | Sell → Neutral | Compass Point |
| 8/4/2023 | $11.00 | Neutral → Sell | Compass Point |
| 4/11/2023 | $12.50 | Buy | Ladenburg Thalmann |
| 12/20/2022 | $11.50 → $10.50 | Mkt Perform → Underperform | Keefe Bruyette |
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that its board of directors has declared monthly cash distributions of $0.11 per share, payable in each of April, May and June 2025. The following tables show these distributions, payable as set forth in the tables below, total $0.33 per share. Since its 2010 initial public offering, Horizon has paid a total of $304 million in distribution
- Fourth Quarter 2024 Net Investment Income per Share of $0.27; NII Covers Regular Monthly Distributions for Year - - NAV per Share of $8.43 - - Debt Portfolio Yield of 14.9% - - HRZN Ends Year with Committed Backlog of $207 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share Through June 2025 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the fourth quarter ended December 31, 2024 on Tuesday, March 4, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, March 5, 2025, at 9:00 a.m. ET. The conference call will feature remarks by Robert D. Pomeroy, Jr., Chairma
Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25
Ladenburg Thalmann downgraded Horizon Technology Finance from Buy to Neutral
B. Riley Securities downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $11.00
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
10-K - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr
FARMINGTON, Conn., June 9, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon," or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that it has appointed Daniel S. Devorsetz as Chief Operating Officer effective immediately. In addition, Devorsetz has concurrently been appointed as Chief Operating Officer of Horizon's external investment advisor, Horizon Technology Finance Management LLC (the "Advisor" or "HTFM"). He currently serves as Chief Investment Of
- Fourth Quarter 2024 Net Investment Income per Share of $0.27; NII Covers Regular Monthly Distributions for Year - - NAV per Share of $8.43 - - Debt Portfolio Yield of 14.9% - - HRZN Ends Year with Committed Backlog of $207 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share Through June 2025 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the fourth quarter ended December 31, 2024 on Tuesday, March 4, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, March 5, 2025, at 9:00 a.m. ET. The conference call will feature remarks by Robert D. Pomeroy, Jr., Chairma
- Third Quarter 2024 Net Investment Income per Share of $0.32; NAV per Share of $9.06 - - Debt Portfolio Yield of 15.9% - - HRZN Ends Quarter with Committed Backlog of $190 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through March 2025 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the third quarter ended September 30, 20